Emmanuelle Crinière

A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

Sophie Camilleri‐Broët, Emmanuelle Crinière, Philippe Broët et al. · Blood · 2005 · 373 citations · Full text

Medicine, Oncology, Pathology +11

Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions

Khê Hoang‐Xuan, L. Capelle, M. Kujas et al. · Journal of Clinical Oncology · 2004 · 357 citations · Full text

Medicine, Neurology, Oncology +14

MGMT methylation: A marker of response to temozolomide in low‐grade gliomas

Sibille Everhard, Gentian Kaloshi, Emmanuelle Crinière et al. · Annals of Neurology · 2006 · 222 citations

Medicine, Neurology, Oncology +15

Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas

Sibille Everhard, Jörg Tost, Hafida El abdalaoui et al. · Neuro-Oncology · 2009 · 179 citations · Full text

Medicine, Molecular Biology, Oncology +17

Prognostic impact of molecular markers in a series of 220 primary glioblastomas

Caroline Houillier, Julie Lejeune, Alexandra Benouaich‐Amiel et al. · Cancer · 2006 · 143 citations · Full text

Medicine, Genetics, Oncology +17